May 20, 2021 | Masters of Pediatrics

Changes in Patent Ductus Arteriosus Treatment Strategy and Respiratory Outcomes in Premature Infants

Experts aspired to explore whether change in patent ductus arteriosus (PDA) management strategies over time had an influence on respiratory outcomes in premature infants. Objective

Targeting Abnormal Cell Metabolism Shows Promise for Treating Pediatric Brain Tumors

Two experimental drug approaches that target vulnerabilities in cancer cell metabolism may extend survival and enhance the effectiveness of standard chemotherapies for a highly aggressive

Masters of Pediatrics™ (MoP) is dedicated to the advancement of healthcare technologies and education serving as the academic home for child health professionals. Masters of Pediatrics offers continuing medical education, activities, and training through its advanced education entity Metabolic Medical Institute (MMI).

A division of Tarsus Medical owned by Tarsus Group

Professional Education

7

Professional Education

7

5

4

5

7

Featured ARTICLES

MIS-C Diagnosed More Often in Black, Hispanic Children

Latest RESEARCH & DATA

Day: May 20, 2021

Changes in Patent Ductus Arteriosus Treatment Strategy and Respiratory Outcomes in Premature Infants

Targeting Abnormal Cell Metabolism Shows Promise for Treating Pediatric Brain Tumors

Professional Education

7

5

4

5

7

Latest Research

MIS-C Diagnosed More Often in Black, Hispanic Children

FDA Says Children as Young as 3 Years Old can Take Epclusa for Hepatitis C

About

+1 (888) 555-1212

START HERE

MEMBERSHIP

Latest RESEARCH & DATA

MIS-C Diagnosed More Often in Black, Hispanic Children

FDA Says Children as Young as 3 Years Old can Take Epclusa for Hepatitis C